Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study
Yongzhen Fan, Tao Guo, Feifei Yan, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients
Carlos Díaz-Arocutipa, Beatriz Melgar-Talavera, A Alvarado-Yarasca, et al.
International Journal of Infectious Diseases (2021) Vol. 110, pp. 374-381
Open Access | Times Cited: 61
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
Lívia Teixeira, Jairo R. Temerozo, Filipe S. Pereira‐Dutra, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis
Αναστάσιος Κόλλιας, Konstantinos G. Kyriakoulis, Ioannis Kyriakoulis, et al.
Atherosclerosis (2021) Vol. 330, pp. 114-121
Open Access | Times Cited: 53
Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis
Amir Vahedian‐Azimi, Seyede Momeneh Mohammadi, Maciej Banach, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 53
The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study
Srikanth Umakanthan, Sanjum Senthil, Stanley John, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis
Chia Siang Kow, Syed Shahzad Hasan
American Journal of Cardiovascular Drugs (2021) Vol. 22, Iss. 2, pp. 167-181
Open Access | Times Cited: 32
Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts
Ahmad Fariz Malvi Zamzam Zein, Catur Setiya Sulistiyana, Uswatun Khasanah, et al.
Postgraduate Medical Journal (2021) Vol. 98, Iss. 1161, pp. 503-508
Open Access | Times Cited: 30
Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS‐CoV‐2
Hua Zhu, Hanwen Zhang, Nina Zhou, et al.
Advanced Science (2021) Vol. 8, Iss. 16
Open Access | Times Cited: 27
Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
Kim Bouillon, Bérangère Baricault, Laura Semenzato, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 19
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19
Chieh-Chen Wu, An-Jen Lee, Chun-Hsien Su, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1450-1450
Open Access | Times Cited: 20
SKI-1/S1P Facilitates SARS-CoV-2 Spike Induced Cell-to-Cell Fusion via Activation of SREBP-2 and Metalloproteases, Whereas PCSK9 Enhances the Degradation of ACE2
Rachid Essalmani, Ursula Andréo, Alexandra Evagelidis, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 360-360
Open Access | Times Cited: 8
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
Geert Byttebier, Luc Belmans, M Alexander, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 9, pp. 2841-2850
Open Access | Times Cited: 18
The Impact of Cardiovascular Risk Factors on the Course of COVID-19
Katarzyna Wilk‐Śledziewska, Piotr Sielatycki, Natalia Uscinska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 8, pp. 2250-2250
Open Access | Times Cited: 11
Prior Statin vs In-Hospital Statin Usage in Severe COVID-19: Review and Meta-Analysis
Iad Alhallak, Hakan Paydak, Jawahar L. Mehta
Current Problems in Cardiology (2023) Vol. 48, Iss. 9, pp. 101810-101810
Open Access | Times Cited: 6
Coronaviruses, cholesterol and statins: Involvement and application for Covid-19
Stéphane Orlowski, Jean‐Jacques Mourad, Antonio Gallo, et al.
Biochimie (2021) Vol. 189, pp. 51-64
Open Access | Times Cited: 15
Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors
Yuji Ikari, Yuya Matsue, Sho Torii, et al.
Circulation Journal (2021) Vol. 85, Iss. 6, pp. 939-943
Open Access | Times Cited: 14
Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis
Zachary A. Yetmar, Supavit Chesdachai, Tarek Kashour, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 13
The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity
Yousef Rasmi, Nadia Heidari, Kevser Kübra Kırboğa, et al.
Clinical Biochemistry (2022) Vol. 104, pp. 1-12
Open Access | Times Cited: 9
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications
Mariana Alves, Marília Andreia Fernandes, Gülistan Bahat, et al.
European Geriatric Medicine (2021) Vol. 12, Iss. 4, pp. 725-739
Open Access | Times Cited: 9
Personalized medicine targeting different ARDS phenotypes: The future of pharmacotherapy for ARDS?
Florian Blanchard, Arthur James, Mona Assefi, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 1, pp. 41-52
Closed Access | Times Cited: 2
Statins - From Lipid-Lowering Benefits to Pleiotropic Effects

IntechOpen eBooks (2023)
Open Access | Times Cited: 2
SKI-1/S1P Facilitates SARS-CoV-2 Spike Induced Cell-To-Cell Fusion via Activation of Srebp-2 and Metalloproteases, Whereas PCSK9 Enhances the Degradation of ACE2
Rachid Essalmani, Ursula Andréo, Alexandra Evagelidis, et al.
(2022)
Open Access | Times Cited: 4
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
Geert Byttebier, Luc Belmans, M Alexander, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top